Jade Biosciences
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn.
Is Jade Biosciences hiring?
Yes — Jade Biosciences has 7 open jobs on JobsRadar right now, across 12 departments and 4 locations. 2 of them were opened in the last 30 days. 6 of them disclose pay, with a median of $205,000 a year and most offers between $182,500 and $266,875. The board was last refreshed on September 8, 2026 at 18:06 UTC.
Frequently asked questions
- Is Jade Biosciences hiring?
- Yes. Jade Biosciences has 7 open jobs on JobsRadar as of September 8, 2026. 2 of them were opened in the last 30 days.
- What roles is Jade Biosciences hiring for?
- Jade Biosciences is hiring for roles in Clinical Development, Development Operations, Medical Affairs and Regulatory, Quality, Medical Writing.
- What does Jade Biosciences pay?
- Across the 6 Jade Biosciences jobs that disclose pay, the median is $205,000 a year, and most offers fall between $182,500 and $266,875.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on September 8, 2026 at 18:06 UTC.